Assembly Biosciences Inc reports results for the quarter ended in June - Earnings Summary

Assembly Biosciences

09/08/2022 23:05

* Assembly Biosciences Inc  ASMB.OQ  reported a quarterly
adjusted
loss of 51 cents​​ per share for the quarter ended in June. The
mean expectation of five analysts for the quarter was for a loss
of 47 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Assembly Biosciences Inc's reported EPS for the quarter
was a
loss of 51 cents​.
    * The mean earnings estimate of analysts had fallen by
about 0.2%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Assembly Biosciences Inc shares had risen by 1.4% this
quarter and lost 8.6% so far this year.
    * The company reported a quarterly loss of $24.46 million.
    * Wall Street's median 12-month price target for Assembly
Biosciences Inc is $11.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 9
at 10:05 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.47          -0.51          Missed
 Mar. 31 2022      -0.47          -0.48          Missed
 Dec. 31 2021      -0.48          -0.38          Beat
 Sep. 30 2021      -0.56          -0.41          Beat